PÚBLICO

NOTRE DAME INTERMÉDICA

HAPVIDA PARTICIPAÇÕES E

PARTICIPAÇÕES S.A.

INVESTIMENTOS S.A.

CNPJ 19.853.511/0001-84

CNPJ 05.197.443/0001-38

Publicly-held company

Publicly-held company

NOTICE TO THE MARKET

BUSINESS COMBINATION BETWEEN GNDI AND HAPVIDA

FINAL CASH PORTION

Notre Dame Intermédica Participações S.A. (B3: GNDI3) (GNDI) and Hapvida

Participações e Investimentos S.A. (B3: HAPV3) (Hapvida and, jointly with GNDI, the Companies), in addition to the notice to the market disclosed on January 20, 2022, regarding the procedures related to the conclusion of the business combination between GNDI and Hapvida (Transaction), inform their respective shareholders that the final value to be received by GNDI shareholders in consideration for the redemption of the redeemable preferred shares of HapvidaCo shall be of R$5.16614751932 for each GNDI common share held at the closing of the trading session of February 11, 2022 (Final Cash Portion).

The Final Cash Portion already considers all the adjustments provided for in the Protocol and Justification, as well as the adjustment by the variation of the CDI over the total amount of R$4,000,000,000.00 as of March 29, 2021 (exclusive) until February 11, 20222 (inclusive), when the Closing will occur.

The payment of the Final Cash Portion and of the Extraordinary Dividends will be made on March 29, 2022.

The amounts mentioned herein are gross and shall be subject to eventual tax impacts on the payment to resident or non-resident shareholders of GNDI, as indicated in the notice to the market disclosed on January 20, 2022.

Finally, the Companies ratify the Final Exchange Ratio disclosed to the market on January 20, 2022, which, including the applicable decimal places, will be of 5.24364185943 Hapvida common shares for each GNDI share.

São Paulo, SP, February 9, 2022

Fortaleza, CE, February 9, 2022

Glauco Desiderio

Mauricio Teixeira

Investors Relations Officer

CFO and Investor Relations Officer

PÚBLICO

Attachments

  • Original Link
  • Original Document
  • Permalink

Disclaimer

Notre Dame Intermédica Participações SA published this content on 09 February 2022 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 09 February 2022 22:28:03 UTC.